Inventor · disambiguated record
Rajesh Chopra
Also filed as: CHOPRA RAJESH
39 granted patents·27 pending applications·556 citations·filing 1999–2024
98Inventor score
Top patents by PatentIndex Score
66 records- 0196US9699079B2Streaming bridge design with host interfaces and network on chip (NoC) layersNetspeed Systems·Filed 2013·Granted Jul 4, 2017·32 cites·20 claims
- 0293US7587643B1System and method of integrated circuit testingT RAM SEMICONDUCTOR INC·Filed 2005·Granted Sep 8, 2009·27 cites·23 claims
- 0392US9493466B2Treatment of cancer with TOR kinase inhibitorsSIGNAL PHARM LLC·Filed 2012·Granted Nov 15, 2016·7 cites·5 claims
- 0492US9037928B2Memory device with background built-in self-testing and background built-in self-repairKLEVELAND BENDIK·Filed 2013·Granted May 19, 2015·32 cites·76 claims
- 0591US8906932B2Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dioneMULLER GEORGE W·Filed 2012·Granted Dec 9, 2014·15 cites·27 claims
- 0690US9857359B2Methods for determining drug efficacy using cereblon-associated proteinsCELGENE CORP·Filed 2013·Granted Jan 2, 2018·11 cites·15 claims
- 0790US9474757B2Methods for treating cancer using TOR kinase inhibitor combination therapySIGNAL PHARM LLC·Filed 2014·Granted Oct 25, 2016·16 cites·20 claims
- 0890US9119854B2Methods for treating cancer using combination therapyCELGENE CORP·Filed 2014·Granted Sep 1, 2015·8 cites·22 claims
- 0989US10996215B2Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancersCELGENE CORP·Filed 2018·Granted May 4, 2021·5 cites·21 claims
- 1089US9587281B2Cereblon isoforms and their use as biomarkers for therapeutic treatmentCELGENE CORP·Filed 2015·Granted Mar 7, 2017·8 cites·31 claims
- 1189US9358232B2Methods for treating cancer using TOR kinase inhibitor combination therapySIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·13 cites·6 claims
- 1286US9361196B2Memory device with background built-in self-repair using background built-in self-testingMOSYS INC·Filed 2014·Granted Jun 7, 2016·9 cites·35 claims
- 1385US9555033B2Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitorsCHOPRA RAJESH·Filed 2011·Granted Jan 31, 2017·6 cites·14 claims
- 1484US6591340B2Microprocessor having improved memory management unit and cache memoryHITACHI LTD·Filed 2002·Granted Jul 8, 2003·35 cites·8 claims
- 1582US10218580B2Generating physically aware network-on-chip design from a physical system-on-chip specificationNetspeed Systems·Filed 2015·Granted Feb 26, 2019·4 cites·18 claims
- 1682US9937170B2Treatment of cancer with TOR kinase inhibitorsSIGNAL PHARM LLC·Filed 2016·Granted Apr 10, 2018·1 cites·5 claims
- 1781US9694015B2Methods for the treatment of locally advanced breast cancerCELGENE CORP·Filed 2013·Granted Jul 4, 2017·5 cites·17 claims
- 1879US2024389562A1Transgenic mouse expressing human cereblonCELGENE CORP·Filed 2024·Application pending·0 cites
- 1978US11119857B2Substitute redundant memorySIKDAR DIPAK K·Filed 2013·Granted Sep 14, 2021·7 cites·76 claims
- 2077US10970734B2Interactive loyalty reward system and methodMASTERCARD INTERNATIONAL INC·Filed 2016·Granted Apr 6, 2021·2 cites·17 claims
- 2177US6412043B1Microprocessor having improved memory management unit and cache memoryHITACHI LTD·Filed 1999·Granted Jun 25, 2002·74 cites·11 claims
- 2276US6598128B1Microprocessor having improved memory management unit and cache memoryHITACHI LTD·Filed 1999·Granted Jul 22, 2003·95 cites·20 claims
- 2375US11615421B2Methods, system and computer program product for selectively responding to presentation of payment card informationMASTERCARD INTERNATIONAL INC·Filed 2018·Granted Mar 28, 2023·1 cites·19 claims
- 2474US2022273650A1Treatment of cancer with tor kinase inhibitorsSIGNAL PHARM LLC·Filed 2021·Application pending·0 cites
- 2572US8988956B2Programmable memory built in self repair circuitMOSYS INC·Filed 2013·Granted Mar 24, 2015·4 cites·32 claims
- 2672US2023159490A1Treatment of immune-related and inflammatory diseasesCELGENE CORP·Filed 2022·Application pending·0 cites
- 2771US11166950B2Treatment of cancer with TOR kinase inhibitorsSIGNAL PHARM LLC·Filed 2018·Granted Nov 9, 2021·0 cites·5 claims
- 2870US8495620B2System and method for application configuration comparison and reuseCHOPRA RAJESH·Filed 2008·Granted Jul 23, 2013·2 cites·19 claims
- 2970US6629207B1Method for loading instructions or data into a locked way of a cache memoryHITACHI LTD·Filed 1999·Granted Sep 30, 2003·58 cites·46 claims
- 3067US11524950B2Treatment of immune-related and inflammatory diseasesCELGENE CORP·Filed 2020·Granted Dec 13, 2022·0 cites·20 claims
- 3167US2022003749A1Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancersCELGENE CORP·Filed 2021·Application pending·0 cites
- 3266US2020113896A1Methods for treating cancer using tor kinase inhibitor combination therapySIGNAL PHARM LLC·Filed 2019·Application pending·0 cites
- 3365US10919883B2Treatment of immune-related and inflammatory diseasesCELGENE CORP·Filed 2013·Granted Feb 16, 2021·0 cites·12 claims
- 3464US2015038511A1Treatment of immune-related and inflammatory diseasesCELGENE CORP·Filed 2014·Application pending·0 cites
- 3563US2015126538A1Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2014·Application pending·0 cites
- 3662US11963520B2Transgenic mouse expressing human cereblonCELGENE CORP·Filed 2017·Granted Apr 23, 2024·0 cites·7 claims
- 3762US8954803B2Programmable test engine (PCDTE) for emerging memory technologiesCHOPRA RAJESH·Filed 2011·Granted Feb 10, 2015·1 cites·32 claims
- 3862US2021340132A1Treatment of immune-related and inflammatory diseasesCELGENE CORP·Filed 2020·Application pending·0 cites
- 3960US9058241B2System and method for application configuration comparison and reuseIBM·Filed 2013·Granted Jun 16, 2015·0 cites·17 claims
- 4059US2018055844A1Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2017·Application pending·0 cites
- 4158US2010305988A1Enhancing Quality of Contact Lists for Direct Marketing CampaignsAMERICAN EXPRESS TRAVEL RELATE·Filed 2009·Application pending·0 cites
- 4257US2021019750A1Methods, systems, and networks for authentication based on physical characteristics of a cardMASTERCARD INTERNATIONAL INC·Filed 2019·Application pending·0 cites
- 4357US2018209961A1Methods for determining drug efficacy using cereblon-associated proteinsCELGENE CORP·Filed 2017·Application pending·0 cites
- 4456US6496905B1Write buffer with burst capabilityHITACHI LTD·Filed 1999·Granted Dec 17, 2002·32 cites·18 claims
- 4555US8291380B2Methods for configuring software packageBANDYOPADHYAY TIRTHANKAR·Filed 2008·Granted Oct 16, 2012·3 cites·13 claims
- 4654US2016313300A1Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancersCELGENE CORP·Filed 2014·Application pending·0 cites
- 4753US10084692B2Streaming bridge design with host interfaces and network on chip (NoC) layersNETSPEED SYSTEMS INC·Filed 2017·Granted Sep 25, 2018·0 cites·20 claims
- 4853US2022242846A1Isoindolinone compoundsMONTE ROSA THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 4953US2014314752A1Methods for treating cancer using tor kinase inhibitor combination therapySIGNAL PHARM LLC·Filed 2014·Application pending·0 cites
- 5052US2017362660A1Cereblon isoforms and their use as biomarkers for therapeutic treatmentCELGENE CORP·Filed 2017·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rajesh Chopra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →